Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review | Zendy

Willemijn Y. van der Plas | Zendy; R. R. Dulfer | Zendy; Anton F. Engelsman | Zendy; Liffert Vogt | Zendy; Martin H. de Borst | Zendy; Tessa M. van Ginhoven | Zendy; Schelto Kruijff | Zendy

Open Access

Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review

Author(s) -

Willemijn Y. van der Plas,

R. R. Dulfer,

Anton F. Engelsman,

Liffert Vogt,

Martin H. de Borst,

Tessa M. van Ginhoven,

Schelto Kruijff

Publication year - 2017

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfx044

Subject(s) - cinacalcet , medicine , parathyroidectomy , end stage renal disease , hyperparathyroidism , urology , secondary hyperparathyroidism , quality of life (healthcare) , stage (stratigraphy) , disease , parathyroid hormone , calcium , nursing , paleontology , biology

Patients with end-stage renal disease (ESRD) have a decreased quality of life (QoL), which is attributable in part to ESRD-related hyperparathyroidism (HPT). Both cinacalcet and parathyroidectomy (PTx) are treatments for advanced HPT, but their effects on QoL are unclear. We performed a systematic review to evaluate the impact of cinacalcet and PTx on QoL.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research